Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP430300.RAns-yMlKgPAk6mO2MlUoAXnm7swARykeAOXR4ti_L2jg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP430300.RAns-yMlKgPAk6mO2MlUoAXnm7swARykeAOXR4ti_L2jg130_assertion type Assertion NP430300.RAns-yMlKgPAk6mO2MlUoAXnm7swARykeAOXR4ti_L2jg130_head.
- NP430300.RAns-yMlKgPAk6mO2MlUoAXnm7swARykeAOXR4ti_L2jg130_assertion description "[Hypermethylation of at least one of the CpG islands analysed (EN1, SCTR, INHBB) occurred in most carcinomas (90%), with EN1 methylated in 73 and 40% of carcinomas and adenomas, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430300.RAns-yMlKgPAk6mO2MlUoAXnm7swARykeAOXR4ti_L2jg130_provenance.
- NP430300.RAns-yMlKgPAk6mO2MlUoAXnm7swARykeAOXR4ti_L2jg130_assertion evidence source_evidence_literature NP430300.RAns-yMlKgPAk6mO2MlUoAXnm7swARykeAOXR4ti_L2jg130_provenance.
- NP430300.RAns-yMlKgPAk6mO2MlUoAXnm7swARykeAOXR4ti_L2jg130_assertion SIO_000772 19384295 NP430300.RAns-yMlKgPAk6mO2MlUoAXnm7swARykeAOXR4ti_L2jg130_provenance.
- NP430300.RAns-yMlKgPAk6mO2MlUoAXnm7swARykeAOXR4ti_L2jg130_assertion wasDerivedFrom befree-20140225 NP430300.RAns-yMlKgPAk6mO2MlUoAXnm7swARykeAOXR4ti_L2jg130_provenance.
- NP430300.RAns-yMlKgPAk6mO2MlUoAXnm7swARykeAOXR4ti_L2jg130_assertion wasGeneratedBy ECO_0000203 NP430300.RAns-yMlKgPAk6mO2MlUoAXnm7swARykeAOXR4ti_L2jg130_provenance.